MODERATE PSORIASIS
Clinical trials for MODERATE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New psoriasis drug shows promise in Long-Term trial
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug ESK-001 for people with moderate to severe plaque psoriasis. Participants are adults who have already completed a prior ESK-001 study. They will take ESK-001 twice daily for 24 weeks, and some may later switch…
Matched conditions: MODERATE PSORIASIS
Phase: PHASE3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New study tracks psoriasis drug in Real-World greek patients
Disease control OngoingThis study follows 250 adults in Greece who were recently diagnosed with moderate plaque psoriasis and are starting risankizumab, a drug that calms the overactive immune system. Researchers will measure how much the skin clears up and how quality of life improves over two years. …
Matched conditions: MODERATE PSORIASIS
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC